Flu epidemic seems to be emerging More and more people in the Netherlands have the flu. The number of people with flu increased significantly last week.
RIVM monitoring local radiological measurements in Ukraine Reports from Ukraine indicate that there was fighting in the vicinity of the Zaporizhzhia nuclear power plant last night. RIVM has been actively monitoring the situation in Ukraine since the start of the disturbances.
General practitioners and occupational physicians not yet connected through Patiëntoverleg app General practitioners’ (GP) and occupational physicians’ (OP) use of the Patiëntoverleg app is still limited. They are often not yet aware of this app’s existence. These findings are from a study performed by RIVM.
RIVM calls for increased involvement of scientific community in solving plastic crisis Industry and policymakers are not availing themselves enough of the available scientific knowledge when it comes to smarter ways of dealing with plastics.
Screening for chronic Q-fever is only cost-effective for specific groups RIVM has investigated for which groups screening for chronic Q-fever might be cost-effective.
Pneumococcal disease in the elderly The Health Council of the Netherlands is preparing an advice on pneumococcal vaccination for the elderly on request of the Ministry of Health, Welfare and Sport.
Statement on health care spending Down syndrome Recently a tweet containing a video from a Dutch tv-show about Down syndrome caused a lot of turmoil on Twitter.
Temporary dermal fillers prove harmless RIVM has conducted a market surveillance study of 26 so-called non-permanent fillers. All 26 products proved to be harmless.
Slight increase of the number of tuberculosis patients in 2016 For the second consecutive year, the number of tuberculosis (TB) patients in the Netherlands increased.
Promising biobased alternatives to controversial polar aprotic solvents There are a number of promising biobased alternatives to controversial polar aprotic solvents, as revealed in a report from Wageningen Food & Biobased Research commissioned by RIVM .